Patient Blood Management: Recommendations from the 2018 Frankfurt Consensus Conference

JAMA - Journal of the American Medical Association

Volumn 321, Issue 10, 2019, Pages 983-997

  Mueller, Markus M ^a   Van Remoortel, Hans ^b   Meybohm, Patrick ^a   Aranko, Kari ^c   Aubron, Cécile ^d,k   Burger, Reinhard ^e   Carson, Jeffrey L ^f   Cichutek, Klaus ^g   De Buck, Emmy ^b,h   Devine, Dana ⁱ   Fergusson, Dean ^j   Folléa, Gilles ^k   French, Craig ^l   Frey, Kathrine P ^m,z   Gammon, Richard ^n,z   Levy, Jerrold H ^o   Murphy, Michael F ^p,z   Ozier, Yves ^d   Pavenski, Katerina ^q   So Osman, Cynthia ^r,s   Tiberghien, Pierre ^t,z   Volmink, Jimmy ^u   Waters, Jonathan H ^v   Wood, Erica M ^s,w   Seifried, Erhard ^a,c,s   Albaladejo, Pierre ^x,y   Allard, Shubha ^p,s   Gabriel, Christian ^aa,ab   Greinacher, Andreas ^ac,ad   Van Kraaij, Marian ^z,ae   Liumbruno, Giancarlo ^z,af   Saxon, Ben ^ag   Shehata, Nadine ^ad,ah   Velati, Claudio ^z,ai   Bischof, Danielle ^ah   Hamilton, Jennifer ⁱ   Lasocki, Sigismond ^ak   Gomez, Manuel Mũoz ^aj   Schmitz Rixen, Thomas ^a   Serve, Hubert ^a   Thomson, Amanda ^ag   Beckers, Erik ^al   Benson, Kaaron ^am   Juffermans, Nicole ^an   Maze, Dawn ^q   Mirski, Marek ^ao   Murphy, Gavin ^ap   Ries, Jean Jacques ^aq   Walsh, Tim ^ar   Anthony, Lauren ^as   Bielby, Linley ^ag   Donald, Graham ^p   Estcourt, Lise ^p   Frank, Steven ^ao   Freedman, John ^at   Humbrecht, Catherine ^t   more..

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Rode Kruis Vlaanderen   (Belgium)

^c European Blood Alliance   (Netherlands)

^d BREST UNIVERSITY HOSPITAL   (France)

^e ROBERT KOCH INSTITUTE   (Germany)

^f ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^g PAUL EHRLICH INSTITUT   (Germany)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ CANADIAN BLOOD SERVICES   (Canada)

^j UNIVERSITY OF OTTAWA   (Canada)

^k Société Française de Transfusion Sanguine SFTS   (France)

^l WESTERN HEALTH   (Australia)

^m UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

ⁿ OneBlood Inc   (United States)

^o DUKE UNIVERSITY MEDICAL CENTER   (United States)

^p NHS BLOOD AND TRANSPLANT   (United Kingdom)

^q UNIVERSITY OF TORONTO   (Canada)

^r GROENE HART HOSPITAL   (Netherlands)

^s International Society for Blood Transfusion   (Netherlands)

^t ETABLISSEMENT FRANÇAIS DU SANG   (France)

^u UNIVERSITY OF STELLENBOSCH   (South Africa)

^v UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^w MONASH UNIVERSITY   (Australia)

^x GRENOBLE UNIVERSITY HOSPITAL   (France)

^y International Society on Thrombosis and Haemostasis ISTH   (France)

^z AABB   (United States)

^aa LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^ab Deutsche Gesellschaft Fr Transfusionsmedizin und Immunhämatologie DGTI   (Germany)

^ac Institut fur Immunologie und Transfusionsmedizin   (Germany)

^ad International Collaboration for Transfusion Medicine Guidelines ICTMG   (United States)

^ae CENTRAL LABORATORY   (Netherlands)

^af ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^ag AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^ah MOUNT SINAI HOSPITAL   (Canada)

^ai Società Italiana di Medicina Trasfusionale e Immunoematologia   (Italy)

^aj UNIVERSITY OF MÁLAGA   (Spain)

^ak ANGERS UNIVERSITY HOSPITAL   (France)

^al MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^am H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^an UNIVERSITY OF AMSTERDAM   (Netherlands)

^ao DEPARTMENT OF PATHOLOGY   (United States)

^ap UNIVERSITY OF LEICESTER   (United Kingdom)

^aq UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ar UNIVERSITY OF EDINBURGH   (United Kingdom)

^as Allina Health Laboratories   (United States)

^at ST MICHAEL'S HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ANEMIA; CONFERENCE PAPER; CRITICALLY ILL PATIENT; DECISION SUPPORT SYSTEM; ELECTIVE SURGERY; ELECTRONIC DECISION SUPPORT SYSTEM; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HUMAN; INTENSIVE CARE; IRON DEFICIENCY ANEMIA; IRON SUPPLEMENTATION; PATIENT BLOOD MANAGEMENT; PATIENT BLOOD MANAGEMENT PROGRAM; PATIENT CARE; PRACTICE GUIDELINE; PREOPERATIVE ANEMIA; PRIORITY JOURNAL; SEPTIC SHOCK; SUPPLEMENTATION; SYSTEMATIC REVIEW; BLOOD TRANSFUSION; CONSENSUS DEVELOPMENT; OPERATIVE BLOOD LOSS; PREOPERATIVE CARE; STANDARDS;

ANEMIA; ANEMIA, IRON-DEFICIENCY; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CRITICAL CARE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEMATINICS; HEMOGLOBINS; HIP FRACTURES; HUMANS; IRON; PREOPERATIVE CARE;

EID: 85062733881     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2019.0554     Document Type: Conference Paper

References (137)

1. World Health Organization (WHO). WHO Global Forum for Blood Safety: patient blood management. WHO website. https://www.who.int/bloodsafety/events/gfbs-01-pbm/en/. Published March 2011. Accessed February 5, 2019.
2. Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012; 116 (6): 1367-1376. doi: 10.1097/ALN.0b013e318254d1a3 22487863
3. Carson JL, Stanworth SJ, Alexander JH, Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. Am Heart J. 2018; 200: 96-101. doi: 10.1016/j.ahj.2018.04.007 29898855
4. Carson JL, Stanworth SJ, Roubinian N, Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016; 10: CD002042. 27731885
5. Desborough MJR, Colman KS, Prick BW, Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: systematic review and meta-analysis. Thromb Haemost. 2017; 117 (5): 889-898. doi: 10.1160/TH17-01-0015 28251234
6. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015; 350: h1354. doi: 10.1136/bmj.h1354 25805204
7. Hovaguimian F, Myles PS. Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology. 2016; 125 (1): 46-61. doi: 10.1097/ALN.0000000000001162 27167445
8. Mao T, Gao F, Han J, Restrictive versus liberal transfusion strategies for red blood cell transfusion after hip or knee surgery: a systematic review and meta-analysis. Medicine (Baltimore). 2017; 96 (25): e7326. doi: 10.1097/MD.0000000000007326 28640148
9. De Buck E, Pauwels NS, Dieltjens T, Vandekerckhove P. Use of evidence-based practice in an aid organisation: a proposal to deal with the variety in terminology and methodology. Int J Evid Based Healthc. 2014; 12 (1): 39-49. doi: 10.1097/01.XEB.0000444637.88465.a3 24685899
10. Guyatt GH, Oxman AD, Vist GE,; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336 (7650): 924-926. doi: 10.1136/bmj.39489.470347.AD 18436948
11. Guyatt G, Oxman AD, Akl EA, GRADE guidelines, 1: introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64 (4): 383-394. doi: 10.1016/j.jclinepi.2010.04.026 21195583
12. Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum. 2011; 41 (2): 95-105. doi: 10.1016/j.semarthrit.2010.12.001 21420149
13. Sher GD, Devine DV. The consensus development process in transfusion medicine: does it add value? Transfusion. 2007; 47 (12): 2176-2179. doi: 10.1111/j.1537-2995.2007.01540.x 18036072
14. Moberg J, Oxman AD, Rosenbaum S,; GRADE Working Group. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst. 2018; 16 (1): 45. doi: 10.1186/s12961-018-0320-2 29843743
15. Blaudszun G, Munting KE, Butchart A, Gerrard C, Klein AA. The association between borderline pre-operative anaemia in women and outcomes after cardiac surgery: a cohort study. Anaesthesia. 2018; 73 (5): 572-578. doi: 10.1111/anae.14185 29349775
16. Carrascal Y, Maroto L, Rey J, Impact of preoperative anemia on cardiac surgery in octogenarians. Interact Cardiovasc Thorac Surg. 2010; 10 (2): 249-255. doi: 10.1510/icvts.2009.220160 19889715
17. Cladellas M, Bruguera J, Comín J, Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement? Eur Heart J. 2006; 27 (9): 1093-1099. doi: 10.1093/eurheartj/ehi830 16537556
18. Dai L, Mick SL, McCrae KR, Preoperative anemia in cardiac operation: does hemoglobin tell the whole story? Ann Thorac Surg. 2018; 105 (1): 100-107. doi: 10.1016/j.athoracsur.2017.06.074 29128046
19. Elmistekawy E, Rubens F, Hudson C, Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur J Cardiothorac Surg. 2013; 44 (6): 1051-1055. doi: 10.1093/ejcts/ezt143 23530025
20. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia. 2011; 66 (9): 812-818. doi: 10.1111/j.1365-2044.2011.06819.x 21790520
21. Joshi SS, George A, Manasa D, Savita HM, Krishna PT, Jagadeesh AM. Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Ann Card Anaesth. 2015; 18 (3): 373-379. doi: 10.4103/0971-9784.159808 26139743
22. Matsuda S, Fukui T, Shimizu J, Takao A, Takanashi S, Tomoike H. Associations between preoperative anemia and outcomes after off-pump coronary artery bypass grafting. Ann Thorac Surg. 2013; 95 (3): 854-860. doi: 10.1016/j.athoracsur.2012.10.005 23219139
23. Miceli A, Romeo F, Glauber M, de Siena PM, Caputo M, Angelini GD. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg. 2014; 9: 137. doi: 10.1186/1749-8090-9-137 25096231
24. Mirhosseini SJ, Sayegh SA. Effect of preoperative anemia on short term clinical outcomes in diabetic patients after elective off-pump CABG surgery. Acta Med Iran. 2012; 50 (9): 615-618. 23165811
25. Muñoz M, Ariza D, Gómez-Ramírez S, Hernández P, García-Erce JA, Leal-Noval SR. Preoperative anemia in elective cardiac surgery: prevalence, risk factors, and influence on postoperative outcome. Transfus Altern Transfus Med. 2010; 11 (2): 47-56. doi: 10.1111/j.1778-428X.2010.01126.x
26. Nuis RJ, Sinning JM, Rodés-Cabau J, Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013; 6 (6): 625-634. doi: 10.1161/CIRCINTERVENTIONS.113.000409 24280965
27. Padmanabhan H, Aktuerk D, Brookes MJ, Anemia in cardiac surgery: next target for mortality and morbidity improvement? Asian Cardiovasc Thorac Ann. 2016; 24 (1): 12-17. doi: 10.1177/0218492315618032 26602161
28. Shirzad M, Karimi A, Dowlatshahi S, Preoperative anemia associated in-hospital mortality and morbidity in isolated coronary bypass graft surgery. Cent Eur J Med. 2010; 5 (3): 308-314.
29. Van Mieghem NM, Nuis RJ, Tzikas A, Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2011; 7 (2): 184-191. doi: 10.4244/EIJV7I2A32 21646060
30. Alan N, Seicean A, Seicean S, Neuhauser D, Weil RJ. Impact of preoperative anemia on outcomes in patients undergoing elective cranial surgery. J Neurosurg. 2014; 120 (3): 764-772. doi: 10.3171/2013.10.JNS131028 24286148
31. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology. 2009; 110 (3): 574-581. doi: 10.1097/ALN.0b013e31819878d3 19212255
32. Bydon M, Abt NB, Macki M, Preoperative anemia increases postoperative morbidity in elective cranial neurosurgery. Surg Neurol Int. 2014; 5: 156. doi: 10.4103/2152-7806.143754 25422784
33. Chamieh JS, Tamim HM, Masrouha KZ, Saghieh SS, Al-Taki MM. The association of anemia and its severity with cardiac outcomes and mortality after total knee arthroplasty in noncardiac patients. J Arthroplasty. 2016; 31 (4): 766-770. doi: 10.1016/j.arth.2015.10.035 26689615
34. Gabriel RA, Clark AI, Nguyen AP, Waterman RS, Schmidt UH. The association of preoperative hematocrit and transfusion with mortality in patients undergoing elective non-cardiac surgery. World J Surg. 2018; 42 (7): 1939-1948. doi: 10.1007/s00268-017-4359-y 29143088
35. Greenky M, Gandhi K, Pulido L, Restrepo C, Parvizi J. Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? Clin Orthop Relat Res. 2012; 470 (10): 2695-2701. doi: 10.1007/s11999-012-2435-z 22773393
36. Gupta PK, Sundaram A, Mactaggart JN, Preoperative anemia is an independent predictor of postoperative mortality and adverse cardiac events in elderly patients undergoing elective vascular operations. Ann Surg. 2013; 258 (6): 1096-1102. doi: 10.1097/SLA.0b013e318288e957 23511839
37. Kim BD, Edelstein AI, Patel AA, Lovecchio F, Kim JY. Preoperative anemia does not predict complications after single-level lumbar fusion: a propensity score-matched multicenter study. Spine (Phila Pa 1976). 2014; 39 (23): 1981-1989. doi: 10.1097/BRS.0000000000000568 25188593
38. Melis M, McLoughlin JM, Dean EM, Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. J Surg Res. 2009; 153 (1): 114-120. doi: 10.1016/j.jss.2008.06.005 19201421
39. Musallam KM, Tamim HM, Richards T, Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011; 378 (9800): 1396-1407. doi: 10.1016/S0140-6736(11)61381-0 21982521
40. Oshin OA, Torella F. Low hemoglobin concentration is associated with poor outcome after peripheral arterial surgery. Vasc Endovascular Surg. 2013; 47 (6): 449-453. doi: 10.1177/1538574413493679 23794093
41. Phan K, Dunn AE, Kim JS, Impact of preoperative anemia on outcomes in adults undergoing elective posterior cervical fusion. Global Spine J. 2017; 7 (8): 787-793. doi: 10.1177/2192568217705654 29238644
42. Phan K, Wang N, Kim JS, Effect of preoperative anemia on the outcomes of anterior cervical discectomy and fusion. Global Spine J. 2017; 7 (5): 441-447. doi: 10.1177/2192568217699404 28811988
43. Saager L, Turan A, Reynolds LF, Dalton JE, Mascha EJ, Kurz A. The association between preoperative anemia and 30-day mortality and morbidity in noncardiac surgical patients. Anesth Analg. 2013; 117 (4): 909-915. doi: 10.1213/ANE.0b013e31828b347d 23492966
44. Seicean A, Seicean S, Alan N, Preoperative anemia and perioperative outcomes in patients who undergo elective spine surgery. Spine (Phila Pa 1976). 2013; 38 (15): 1331-1341. doi: 10.1097/BRS.0b013e3182912c6b 23524867
45. Tee MC, Shubert CR, Ubl DS, Habermann EB, Nagorney DM, Que FG. Preoperative anemia is associated with increased use of hospital resources in patients undergoing elective hepatectomy. Surgery. 2015; 158 (4): 1027-1036. doi: 10.1016/j.surg.2015.06.004 26162941
46. Tohme S, Varley PR, Landsittel DP, Chidi AP, Tsung A. Preoperative anemia and postoperative outcomes after hepatectomy. HPB (Oxford). 2016; 18 (3): 255-261. doi: 10.1016/j.hpb.2015.09.002 27017165
47. Velescu A, Clará A, Cladellas M, Anemia increases mortality after open or endovascular treatment in patients with critical limb ischemia: a retrospective analysis. Eur J Vasc Endovasc Surg. 2016; 51 (4): 543-549. doi: 10.1016/j.ejvs.2015.12.006 26810343
48. Wu WC, Schifftner TL, Henderson WG, Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007; 297 (22): 2481-2488. doi: 10.1001/jama.297.22.2481 17565082
49. Zhang L, Hiebert B, Zarychanski R, Arora RC; Cardiovascular Health Research in Manitoba (CHaRM) Investigator Group. Preoperative anemia does not increase the risks of early surgical revascularization after myocardial infarction. Ann Thorac Surg. 2013; 95 (2): 542-547. doi: 10.1016/j.athoracsur.2012.07.011 22939451
50. Muñoz M, Naveira E, Seara J, Palmer JH, Cuenca J, García-Erce JA. Role of parenteral iron in transfusion requirements after total hip replacement: a pilot study. Transfus Med. 2006; 16 (2): 137-142. doi: 10.1111/j.1365-3148.2005.00629.x 16623920
51. Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br J Surg. 2009; 96 (10): 1122-1128. doi: 10.1002/bjs.6688 19731228
52. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016; 264 (1): 41-46. doi: 10.1097/SLA.0000000000001646 26817624
53. Lidder PG, Sanders G, Whitehead E, Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery-a prospective, randomised, controlled trial. Ann R Coll Surg Engl. 2007; 89 (4): 418-421. doi: 10.1308/003588407X183364 17535624
54. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surg Today. 2005; 35 (1): 36-40. doi: 10.1007/s00595-004-2888-0 15622462
55. Bedair H, Yang J, Dwyer MK, McCarthy JC. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective. Clin Orthop Relat Res. 2015; 473 (2): 590-596. doi: 10.1007/s11999-014-3819-z 25106796
56. Weltert L, D'Alessandro S, Nardella S, Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010; 139 (3): 621-626. doi: 10.1016/j.jtcvs.2009.10.012 20042202
57. Weltert L, Rondinelli B, Bello R, A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015; 55 (7): 1644-1654. doi: 10.1111/trf.13027 25702777
58. Christodoulakis M, Tsiftsis DD; Hellenic Surgical Oncology Perioperative EPO Study Group. Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study. Ann Surg Oncol. 2005; 12 (9): 718-725. doi: 10.1245/ASO.2005.06.031 16052276
59. Dousias V, Paraskevaidis E, Dalkalitsis N, Tsanadis G, Navrozoglou I, Lolis D. Recombinant human erythropoietin in mildly anemic women before total hysterectomy. Clin Exp Obstet Gynecol. 2003; 30 (4): 235-238. 14664421
60. Faris PM, Ritter MA, Abels RI; American Erythropoietin Study Group. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg Am. 1996; 78 (1): 62-72. doi: 10.2106/00004623-199601000-00009 8550681
61. Feagan BG, Wong CJ, Kirkley A, Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty: a randomized, controlled trial. Ann Intern Med. 2000; 133 (11): 845-854. doi: 10.7326/0003-4819-133-11-200012050-00008 11103054
62. Heiss MM, Tarabichi A, Delanoff C, Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study. Surgery. 1996; 119 (5): 523-527. doi: 10.1016/S0039-6060(96)80261-3 8619207
63. Kettelhack C, Hönes C, Messinger D, Schlag PM. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg. 1998; 85 (1): 63-67. doi: 10.1046/j.1365-2168.1998.00564.x 9462386
64. Kosmadakis N, Messaris E, Maris A, Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study. Ann Surg. 2003; 237 (3): 417-421. doi: 10.1097/01.SLA.0000055275.38740.56 12616127
65. Larson B, Bremme K, Clyne N, Nordström L. Preoperative treatment of anemic women with epoetin beta. Acta Obstet Gynecol Scand. 2001; 80 (6): 559-562. doi: 10.1080/j.1600-0412.2001.080006559.x 11380294
66. Laupacis A, Feagan B, Wong C; COPES Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet. 1993; 342 (8867): 378. doi: 10.1016/0140-6736(93)91527-S 8101624
67. Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion. 2011; 51 (1): 118-124. doi: 10.1111/j.1537-2995.2010.02783.x 20624257
68. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery-prospective double-blind placebo-controlled study. World J Surg. 1999; 23 (1): 30-35. doi: 10.1007/s002689900561 9841760
69. Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study. Laryngoscope. 2002; 112 (7, pt 1): 1221-1229. doi: 10.1097/00005537-200207000-00015 12169903
70. So-Osman C, Nelissen RG, Koopman-van Gemert AW, Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology. 2014; 120 (4): 852-860. doi: 10.1097/ALN.0000000000000135 24434302
71. Stowell CP, Jones SC, Enny C, Langholff W, Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine (Phila Pa 1976). 2009; 34 (23): 2479-2485. doi: 10.1097/BRS.0b013e3181bd163f 19927096
72. Weber EW, Slappendel R, Hémon Y, Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol. 2005; 22 (4): 249-257. doi: 10.1017/S0265021505000426 15892401
73. Wurnig C, Schatz K, Noske H,; Collaborative Study Group. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation. Eur Surg Res. 2001; 33 (5-6): 303-310. doi: 10.1159/000049723 11805389
74. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011; 115 (5): 929-937. doi: 10.1097/ALN.0b013e318232004b 22027622
75. Bergamin FS, Almeida JP, Landoni G, Liberal versus restrictive transfusion strategy in critically ill oncologic patients: the Transfusion Requirements in Critically Ill Oncologic Patients randomized controlled trial. Crit Care Med. 2017; 45 (5): 766-773. doi: 10.1097/CCM.0000000000002283 28240687
76. Hébert PC, Wells G, Blajchman MA,; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999; 340 (6): 409-417. doi: 10.1056/NEJM199902113400601 9971864
77. Hébert PC, Wells G, Marshall J,; Canadian Critical Care Trials Group. Transfusion requirements in critical care: a pilot study. JAMA. 1995; 273 (18): 1439-1444. doi: 10.1001/jama.1995.03520420055038 7723158
78. Holst LB, Haase N, Wetterslev J,; TRISS Trial Group; Scandinavian Critical Care Trials Group. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371 (15): 1381-1391. doi: 10.1056/NEJMoa1406617 25270275
79. Palmieri TL, Holmes JH IV, Arnoldo B, Transfusion Requirement in Burn Care Evaluation (TRIBE): a multicenter randomized prospective trial of blood transfusion in major burn injury. Ann Surg. 2017; 266 (4): 595-602. doi: 10.1097/SLA.0000000000002408 28697050
80. Walsh TS, Boyd JA, Watson D,; RELIEVE Investigators. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med. 2013; 41 (10): 2354-2363. doi: 10.1097/CCM.0b013e318291cce4 23939351
81. Bracey AW, Radovancevic R, Riggs SA, Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999; 39 (10): 1070-1077. doi: 10.1046/j.1537-2995.1999.39101070.x 10532600
82. Hajjar LA, Vincent JL, Galas FR, Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304 (14): 1559-1567. doi: 10.1001/jama.2010.1446 20940381
83. Johnson RG, Thurer RL, Kruskall MS, Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg. 1992; 104 (2): 307-314. 1495291
84. Koch CG, Sessler DI, Mascha EJ, A randomized clinical trial of red blood cell transfusion triggers in cardiac surgery. Ann Thorac Surg. 2017; 104 (4): 1243-1250. doi: 10.1016/j.athoracsur.2017.05.048 28821336
85. Laine A, Niemi T, Schramko A. transfusion threshold of hemoglobin 80 g/L is comparable to 100 g/L in terms of bleeding in cardiac surgery: a prospective randomized study. J Cardiothorac Vasc Anesth. 2018; 32 (1): 131-139. doi: 10.1053/j.jvca.2017.08.039 29126686
86. Mazer CD, Whitlock RP, Fergusson DA,; TRICS Investigators and Perioperative Anesthesia Clinical Trials Group. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017; 377 (22): 2133-2144. doi: 10.1056/NEJMoa1711818 29130845
87. Murphy GJ, Pike K, Rogers CA,; TITRe2 Investigators. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015; 372 (11): 997-1008. doi: 10.1056/NEJMoa1403612 25760354
88. Shehata N, Burns LA, Nathan H, A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion. 2012; 52 (1): 91-99. doi: 10.1111/j.1537-2995.2011.03236.x 21790621
89. Carson JL, Terrin ML, Barton FB, A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 1998; 38 (6): 522-529. doi: 10.1046/j.1537-2995.1998.38698326331.x 9661685
90. Carson JL, Terrin ML, Noveck H,; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365 (26): 2453-2462. doi: 10.1056/NEJMoa1012452 22168590
91. Fan YX, Liu FF, Jia M, Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Arch Gerontol Geriatr. 2014; 59 (1): 181-185. doi: 10.1016/j.archger.2014.03.009 24745810
92. Foss NB, Kristensen MT, Jensen PS, Palm H, Krasheninnikoff M, Kehlet H. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion. 2009; 49 (2): 227-234. doi: 10.1111/j.1537-2995.2008.01967.x 19389209
93. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial. Acta Orthop. 2015; 86 (3): 363-372. doi: 10.3109/17453674.2015.1006980 25586270
94. Grover M, Talwalkar S, Casbard A, Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang. 2006; 90 (2): 105-112. doi: 10.1111/j.1423-0410.2006.00730.x 16430668
95. Lotke PA, Barth P, Garino JP, Cook EF. Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. J Arthroplasty. 1999; 14 (6): 647-650. doi: 10.1016/S0883-5403(99)90216-4 10512433
96. Nielsen K, Johansson PI, Dahl B, Perioperative transfusion threshold and ambulation after hip revision surgery-a randomized trial. BMC Anesthesiol. 2014; 14: 89. doi: 10.1186/1471-2253-14-89 25337035
97. Parker MJ. Randomised trial of blood transfusion versus a restrictive transfusion policy after hip fracture surgery. Injury. 2013; 44 (12): 1916-1918. doi: 10.1016/j.injury.2013.04.033 23756263
98. So-Osman C, Nelissen R, Brand R, The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013; 11 (2): 289-295. 23399367
99. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 1986; 73 (10): 783-785. doi: 10.1002/bjs.1800731007 3533203
100. Jairath V, Kahan BC, Gray A, Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 2015; 386 (9989): 137-144. doi: 10.1016/S0140-6736(14)61999-1 25956718
101. Villanueva C, Colomo A, Bosch A, Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013; 368 (1): 11-21. doi: 10.1056/NEJMoa1211801 23281973
102. Fisher MR, Topley E. The illness of trauma. Br J Clin Pract. 1956; 10 (11): 770-776. 13374186
103. Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, Pendry K; British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015; 170 (6): 788-803. doi: 10.1111/bjh.13580 26147359
104. Frank SM, Thakkar RN, Podlasek SJ, Implementing a health system-wide patient blood management program with a clinical community approach. Anesthesiology. 2017; 127 (5): 754-764. doi: 10.1097/ALN.0000000000001851 28885446
105. Frew N, Alexander D, Hood J, Acornley A. Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty. Ann R Coll Surg Engl. 2016; 98 (6): 380-386. doi: 10.1308/rcsann.2016.0139 27055406
106. Gani F, Cerullo M, Ejaz A, Implementation of a blood management program at a tertiary care hospital: effect on transfusion practices and clinical outcomes among patients undergoing surgery [published online November 2, 2017]. Ann Surg. 2017. doi: 10.1097/SLA.0000000000002585 29099397
107. Gross I, Seifert B, Hofmann A, Spahn DR. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion. 2015; 55 (5): 1075-1081. doi: 10.1111/trf.12946 25565302
108. Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S. Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. Oncologist. 2016; 21 (3): 327-332. doi: 10.1634/theoncologist.2015-0406 26865590
109. Kansagra A, Andrzejewski C, Krushell R, Blood management strategies to reduce transfusions after elective lower-extremity joint arthroplasty surgeries: one tertiary care hospital's early experience with an alternative payment model-a total joint "bundle". Am J Med Qual. 2017; 32 (6): 668-674. doi: 10.1177/1062860616687035 28107785
110. Kopanidis P, Hardidge A, McNicol L, Tay S, McCall P, Weinberg L. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty. J Orthop Surg Res. 2016; 11: 28. doi: 10.1186/s13018-016-0358-1 26927608
111. Leahy MF, Hofmann A, Towler S, Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017; 57 (6): 1347-1358. doi: 10.1111/trf.14006 28150313
112. Leahy MF, Roberts H, Mukhtar SA,; Western Australian Patient Blood Management Program. A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion. 2014; 54 (4): 1133-1145. doi: 10.1111/trf.12362 23927725
113. Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. Transfusion. 2017; 57 (9): 2189-2196. doi: 10.1111/trf.14191 28671296
114. Loftus TJ, Spratling L, Stone BA, Xiao L, Jacofsky DJ. A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes. J Arthroplasty. 2016; 31 (1): 11-14. doi: 10.1016/j.arth.2015.07.040 26346704
115. Mehra T, Seifert B, Bravo-Reiter S, Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion. 2015; 55 (12): 2807-2815. doi: 10.1111/trf.13260 26264557
116. Meybohm P, Herrmann E, Steinbicker AU,; PBM-Study Collaborators. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome: a prospective, multicenter cohort study with a noninferiority design. Ann Surg. 2016; 264 (2): 203-211. doi: 10.1097/SLA.0000000000001747 27163948
117. Rineau E, Chaudet A, Chassier C, Bizot P, Lasocki S. Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. Transfusion. 2016; 56 (3): 673-681. doi: 10.1111/trf.13468 26748489
118. Ternström L, Hyllner M, Backlund E, Schersten H, Jeppsson A. A structured blood conservation programme reduces transfusions and costs in cardiac surgery. Interact Cardiovasc Thorac Surg. 2014; 19 (5): 788-794. doi: 10.1093/icvts/ivu266 25125140
119. Thakkar RN, Lee KH, Ness PM, Relative impact of a patient blood management program on utilization of all three major blood components. Transfusion. 2016; 56 (9): 2212-2220. doi: 10.1111/trf.13718 27383581
120. Theusinger OM, Kind SL, Seifert B, Borgeat L, Gerber C, Spahn DR. Patient blood management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfus. 2014; 12 (2): 195-203. 24931841
121. Verdecchia NM, Wisniewski MK, Waters JH, Triulzi DJ, Alarcon LH, Yazer MH. Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: a 9-year follow-up. Hematology. 2016; 21 (8): 490-499. doi: 10.1080/10245332.2015.1112496 26870887
122. Xydas S, Magovern CJ, Slater JP, Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program. J Thorac Cardiovasc Surg. 2012; 143 (4): 926-935. doi: 10.1016/j.jtcvs.2012.01.003 22285327
123. Yaffee DW, Smith DE III, Ursomanno PA, Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy. Ann Thorac Surg. 2014; 97 (1): 95-101. doi: 10.1016/j.athoracsur.2013.09.057 24263014
124. Rothschild JM, McGurk S, Honour M, Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007; 47 (2): 228-239. doi: 10.1111/j.1537-2995.2007.01093.x 17302768
125. Adams ES, Longhurst CA, Pageler N, Widen E, Franzon D, Cornfield DN. Computerized physician order entry with decision support decreases blood transfusions in children. Pediatrics. 2011; 127 (5): e1112-e1119. doi: 10.1542/peds.2010-3252 21502229
126. Goodnough LT, Maggio P, Hadhazy E, Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion. 2014; 54 (10, pt 2): 2753-2759. doi: 10.1111/trf.12723 24995770
127. Kassakian SZ, Yackel TR, Deloughery T, Dorr DA. Clinical decision support reduces overuse of red blood cell transfusions: interrupted time series analysis. Am J Med. 2016; 129 (6): 636.e13-636.e20. doi: 10.1016/j.amjmed.2016.01.024 26873112
128. De Leeuw NK, Lowenstein L, Hsieh YS. Iron deficiency and hydremia in normal pregnancy. Medicine (Baltimore). 1966; 45 (4): 291-315. doi: 10.1097/00005792-196607000-00002 5946689
129. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q. 1985; 38 (3): 302-316. 3878044
130. Food and Agriculture Organization of the United Nations, World Health Organization (WHO). World Declaration and Plan of Action for Nutrition: International Conference on Nutrition. WHO website. https://www.who.int/nutrition/publications/policies/icn-worlddeclaration-planofaction1992/en/. Published 1992. Accessed February 5, 2019.
131. Kilpatrick GS, Hardisty RM. The prevalence of anaemia in the community: a survey of a random sample of the population. Br Med J. 1961; 1 (5228): 778-782. doi: 10.1136/bmj.1.5228.778 13830948
132. Natvig K. Studies on hemoglobin values in Norway, V: hemoglobin concentration and hematocrit in men aged 15-21 years. Acta Med Scand. 1966; 180 (5): 613-620. doi: 10.1111/j.0954-6820.1966.tb02877.x 5923383
133. Sturgeon P. Studies of iron requirements in infants, III: influence of supplemental iron during normal pregnancy on mother and infant. Br J Haematol. 1959; 5 (1): 31-44. doi: 10.1111/j.1365-2141.1959.tb04011.x 13628927
134. World Health Organization (WHO), Centers for Disease Control and Prevention. Assessing the Iron Status of Populations. Second edition, including literature reviews. WHO website. https://www.who.int/nutrition/publications/micronutrients/anaemia-iron-deficiency/9789241596107/en/. Published 2004. Accessed February 5, 2019.
135. Hiscock R, Kumar D, Simmons SW. Systematic review and meta-analysis of method comparison studies of Masimo pulse co-oximeters (Radical-7™ or Pronto-7™) and HemoCue® absorption spectrometers (B-Hemoglobin or 201+) with laboratory haemoglobin estimation. Anaesth Intensive Care. 2015; 43 (3): 341-350. 25943608
136. Wittenmeier E, Bellosevich S, Mauff S, Comparison of the gold standard of hemoglobin measurement with the clinical standard (BGA) and noninvasive hemoglobin measurement (SpHb) in small children: a prospective diagnostic observational study. Paediatr Anaesth. 2015; 25 (10): 1046-1053. doi: 10.1111/pan.12683 26179143
137. Carson JL, Guyatt G, Heddle NM, Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016; 316 (19): 2025-2035. doi: 10.1001/jama.2016.9185 27732721